An interdisciplinary team of scientists from KU Leuven, the University of Bremen, the Leibniz Institute of Materials Engineering, and the University of Ioannina has succeeded in killing tumour cells in mice using nano-sized copper compounds together with immunotherapy. After the therapy, the cancer did not return.
Welcome to the Leuven Cancer Institute, the LKI. The LKI unites doctors, caretakers and researches of University Hospitals Leuven and the KU Leuven in their fight against cancer. The LKI strives to coordinate research, therapy and care in the best way possible. We invest in targeted projects and incorporate innovative technologies, spanning several domains of cancer.
Together we can achieve progress faster and play a leading role in the battle against cancer. Every ally, each partner makes us stronger. Thank you for your support.
Prof. dr. Michel Delforge, chairman of the LKI
